chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shooting pains in neck and shoulder on the side where had vaccine, beginning approx. a week later. Sharp, shooting pains in top part of left ear. See attached email. No follow up from employee until a month later. Had been hospitalized for cardiac condition.
Chest XRay. Result Pneumonitis; Shortness of breath; This is a spontaneous report from a contactable consumer or other non hcp.  A 60-years-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, dose1 (Lot number EN6202, expiry date was not reported) via unspecified route of administration at Left arm on 01Mar2021 at 12:00 PM as a single dose for COVID-19 immunisation. dose 2 (Lot Number: ER8727 expiry date was not reported) via an unspecified route of administration at Arm Left on an unspecified date as a single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient known allergies included Demerol, Morphine, Codiene. The patient previously took demerol apap and, morphine and, codeine and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Adverse event treatment chest XRay. Result Pneumonitis - Proair inhaler ve. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced, result pneumonitis on an unspecified, shortness of breath on 23Mar2021. patient underwent lab tests chest X-ray witch result pneumonitis. Therapeutic measures were taken as a result of shortness of breath Proair inhaler for (pneumonitis). The outcome of the event pneumonitis was unknown, shortness of breath was recovered on an unspecified date 2021.
He had a fever; he had one time 104, in the second one 101; This is a spontaneous report from a contactable consumer (parent). A 16-year-old male patient (reporter's son) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot/Batch number was not reported) via an unspecified route of administration on 16May2021 at 11:00 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 17May2021 at 11:00, the patient had a fever, he had one time 104, in the second one 101. On 17May2021, the patient underwent lab tests and procedures which included body temperature: 104 and body temperature: 101. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Immunizing technician thinks she may have stuck herself when uncapping the needle before injecting patient. She did not realize it at that time. Her finger was bleeding when she took her glove off to wash her hands, after the vaccination, but since she had activated the safety needle inside the patient's arm, she is not sure. I was observing the technician and did not see a needlestick. Technician does consent to blood testing. Patient sat in observation area for 15 minutes and was fine. I let her know what happened and apologized.  She did not seem too concerned. She said she was fine.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Allergic: Rash Generalized-Severe, Systemic: Patient stated pain at injection site, redness, hot the touch, and a knot under skin the size of 1/2 golf ball-Severe, Additional Details: The patient had some pain at injection site the night of shot, when woke up there was a small knot the size of a 1/2 golf ball with redness and heat.  She said the knot grew to the size of 1/2 orange, pain worsened, hot and redness about 3 inches around injection site.  Her home health nose told her to apply Hydrocortisone cream.  I recommended her to take Benadryl and contact primary care physician to determine plan of action.
Vomiting-4+hrs; Pain-eyes,teeth,muscles,body; headache; fever-103; -for approximately 20 hours;followed by muscle spasms in rib/ abdominal area for approximately 6hours with rash from neck covering upper chest- red painful itchy; third day fatigue and nausea
Legs ache/cramp when standing or walking.  Unknown cause--not circulatory or nervous system.  Taken off medication-Atorvastatin.  Stopped taking the Vitamin D/Calcium.  High Blood Pressure is being controlled.  Using a CPAP machine (1 month now) for treatment of sleep apnia.
This nurse removed opened vial of Moderna from storage, 2-8 C. Placed in cooler with ice packs along with two other unopened vials of Moderna. This nurse then transported and gave the three vials to the agency nurse. Agency nurse administered open vial of Moderna to persons who had signed up for the Booster vaccination of the Moderna Vaccination 0.25ml. Once completed updated Manager that the bottle given to her was open and was going to open another vial. This nurse confirmed with the manager that the bottle had been opened previously, 1/19/2022. This nurse had misread the storage information regarding Moderna to be stored unopened and unused for 30 days. This nurse made telephone call to each person affected by this opened vial. Per Medical Director Dr., offered everyone a dose of 0.25ml out of the new unopened vial. RN.
Dizziness, Headache, Arthralgia, tingling in the face, lips and throat, throat hoarseness   Narrative:  Employee felt she was having an anaphylactic reaction. She took benadryl and then went to the ER. She state she waited two hours there and then left without being seen because she felt better, Once home, she continued with intermittent numbness and tingling in face, throat and lips. She took more Benadryl and feels better today.
Heart attack; Very high anxiety; Heart racing; uncomfortable chest; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jun2021 14:00 (Lot number: EW0179) at the age of 54 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing, notes: Was covid prior vaccination) Concomitant medication(s) included: LUNESTA. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0170, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 28Apr2021, when the patient was 54 years old, for COVID-19 immunization.  The following information was reported: MYOCARDIAL INFARCTION (medically significant) with onset 13Jun2021, outcome "recovered with sequelae" (2021), described as "Heart attack"; ANXIETY (non-serious) with onset 13Jun2021, outcome "recovered with sequelae" (2021), described as "Very high anxiety"; PALPITATIONS (non-serious) with onset 13Jun2021, outcome "recovered with sequelae" (2021), described as "Heart racing"; CHEST DISCOMFORT (non-serious) with onset 13Jun2021, outcome "recovered with sequelae" (2021), described as "uncomfortable chest". The events "heart attack", "very high anxiety", "heart racing" and "uncomfortable chest" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (22Jun2021) negative, notes: Nasal Swab; (03Jul2021) negative, notes: Nasal Swab. Therapeutic measures were not taken as a result of myocardial infarction, anxiety, palpitations, chest discomfort. The events were not life threatening, did not caused/prolonged hospitalization, did not result in death, did not result in disabling/incapacitating nor a congenital anomaly/birth defect. The patient did not receive any other vaccine in four weeks. The events were not life threatening, did not caused/prolonged hospitalization, did not result in death, did not result in disabling/incapacitating nor a congenital anomaly/birth defect. The patient was covid prior vaccination and tested covid post vaccination. The patient had no known allergies. After the second source, patient became very anxious. Very high anxiety (which the patient never had). The patient actually thought had a heart attack while on vacation.It was significant anxiety for about 5-6 hours - heart racing, uncomfortable chest. The patient was checking while on vacation before but this started before vacation, continued on vacation and then continues after vacation for about 3-4 months. At the time of report now just have light anxiety but it had not gone away. The patient saw a heart doctor.   No follow-up attempts are possible. No further information is expected.   Follow-Up (03Jan2022): Follow-up attempts are completed. No further information is expected.
Pt devel febrile seizure 102-103; 8AM 19JUL91 body stiffness, eyes rolled in head of pt & was foaming @ mouth per grandma;
R post humeral (upper arm)-about 15 scattered and clustered pinpoint to 1/8cm pink macular and papules-bug bite appearing, starting yesterday 2/4/03 with no change.
they administered 7 doses of an expired vial to 7 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (they administered 7 doses of an expired vial to 7 patients) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 077C21B) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (they administered 7 doses of an expired vial to 7 patients). On 19-Jan-2022, EXPIRED PRODUCT ADMINISTERED (they administered 7 doses of an expired vial to 7 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   HCP stated they administered 7 doses of an expired vial of Moderna COVID-19 Vaccine to 7 patients on 19Jan2022. Caller mentioned no adverse events were observed in any of the patients. HCP stated no treatment was given and patients were not under any concomitant or regular medication.
Patient called 9/23/23 to report a adverse reaction from vaccine on 9/18/23.  Patient states the side effect started the morning of 9/23/23 when she called.  Patient complained of a swollen arm around the injection site and that the lump was about the size of 1/2-1 baseball.  Patient stated it was not red or hot to the touch and that she was going to be icing it.
3" diameter rash on the left arm injection site is itching; Rash on ankle/ Rash spread to elbows and knees; 3" diameter rash on the left arm injection site is itching; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PRURITUS (3" diameter rash on the left arm injection site is itching), RASH (Rash on ankle/ Rash spread to elbows and knees) and VACCINATION SITE RASH (3" diameter rash on the left arm injection site is itching) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Dec-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In December 2022, the patient experienced VACCINATION SITE PRURITUS (3" diameter rash on the left arm injection site is itching), RASH (Rash on ankle/ Rash spread to elbows and knees) and VACCINATION SITE RASH (3" diameter rash on the left arm injection site is itching). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (3" diameter rash on the left arm injection site is itching) had not resolved and RASH (Rash on ankle/ Rash spread to elbows and knees) and VACCINATION SITE RASH (3" diameter rash on the left arm injection site is itching) was resolving.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was reported that there was no parental vaccine exposure.  Patient previously received 4 Moderna monovalent doses (2 primary and 2 booster).  On 02-Dec-2022, patient received a Bivalent Booster and noticed a rash on ankle on Monday.  In one week the rash spread to elbows and knees, 3 inch diameter rash on the left arm injection site was itching. Patient used hydrocortisone topical and some sunburn products.  Patient not visited the doctor.  On the day of reporting, the rash was improving.   This case was linked to MOD-2022-688926 (Patient Link).
The symptoms began 10 minutes after administration of the vaccine on 2/9. The symptoms were: dizzy, lightheaded but BP elevated to 140s systolic, chest tightness, globus sensation with some difficulty swallowing but able to swallow zyrtec then head pain / headache that radiates down to neck. Given zyrtec. Not SOB and not wheezing, no rash or objective swelling of the face or oropharynx. The nurse reports that she cannot move her tongue very well.  The treatment of the reaction was:   o Antihistamines: zyrtec 10mg  o Sent patient to ED
on  the patients PQCF every question was a no,pt showed no fears for needles or signs of aversion,afetr administeru=ing the vaccine pt was waiting for 15 mins sitted ,after 5 mins or more he stated that he could not see,he went blind momentarily, would not blink after a waved my hands across his eyes,we initiated a call to 911 and made him comfortable no other signs of syncope was observed ,he was very aware and calm,after acouple more minutes he regained his sight and at this time he broke out in sweat and was clammy, he felt a lot better with the fan on him and drank  some water and ate some chocolate and after a couple more mins he was good to go home,checked up him again the next day and everything is normal
Right arm pain and weakness at vaccine site at 4:30pm, weird dizzy feeling and chills and fuzzy feeling in head at 5:15pm, took temp, 100 degrees at 6pm, sharp headache on right side of head at 8pm, bad headache and right eyeball ache at 9pm, and 100.2 degree fever, all on 8/14/18, on day of vaccine. Next day, 8/15/2018, 100.3 degree fever, right arm ache at vaccine site, chills and sweats alternating, nauseous, stomach ache, intense headache and eyeball ache on right side, exhausted and weak feeling, alternating chills and sweats.
Headache, Myalgia, NauseaVomiting, Chills, Pain at left arm radiating to left neck Narrative:
A non-serious, spontaneous report of administration to a pregnant women was received from a consumer, concerning a 39 year-old female.  Neither relevant medical history nor concomitant medications have been reported for this patient.  The patient received FLUMIST on 24-OCT-2008, "around the time of conception."  No adverse events have been reported in the patient.  The outcome for the pregnancy is not yet available.
Tb insert site extremely red swollen and painful. Pictures were taken at emergency room by doctor. Hypersensitive reaction from Tb and vaccine at same time.
Fatigue; High fever (102-103 degrees F); severe body aches; head ache; This is a spontaneous report from a non-contactable other hcp (patient). A 38-year-old male patient received their second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on 22Jan2021 13:00 at single dose for COVID-19 immunization. Medical history included slight hypertension and acid reflux from an unknown date and unknown if ongoing. Concomitant medication included propranolol and lansoprazole (PREVACID). The patient previously received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported) on 01Jan2021 at the age of 38 years for COVID-19 immunization. The patient experienced fatigue, high fever, severe body aches and head ache on 22Jan2021 21:00. The patient underwent lab tests and procedures which included body temperature: 102-103 degrees fahrenheit on 22Jan2021. The patient was recovering from the events.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
8/27 1:45pm adm Zostavax subQ--right arm. 8/27 7:00pm right arm began to itch. 8/28 6:00am right arm swollen & redness. 8/29 6:00am right arm more swollen with red shingles type rash & gland in right arm pit was swollen. 8/29 12:00pm developed headache & body pain. 8/30  all symptoms continues & pain worsened. 8/31 morning-went to urgent care--Dr confirmed shingles & prescribed hydrocodone for pain and acyclovir for virus. 9/1/15 Morning-upper torso & face covered with spots and right arm pain was worse--went to Emerency Room---Dr examined patient and confirmed both shingles & chicken pox--was very contagious and sent home--Patient become nausceous & could not eat & went on liquid diet. 9/3--PCP talked with patient and prescribed gabapentin--patient started med. 9/4--Patient pain is better and chicken pox rash is going away and shingles rash is better.
10 days following the vaccine, pt began to have pain and progressive weakness of her left arm and left leg.  She was evaluated at hospital and found on MRI to have areas of demyelination of her brain and spine.  3/16/09-records received-Admitted 1/25/09 via ED with C/O left-sided weakness over last several days.1/26/09-Neurological consult assessment:ADEM probably assoicated with menactra vaccine.
inconsolable irritability & crying for >3-4hr w/in 24hr of vax;
Systemic: Allergic: Anaphylaxis-Severe, Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Hypotension-Severe, Systemic: Weakness-Severe, Additional Details: AFTER VACCINE GIVEN, PT COMPLAINED SHE DIDNT FEEL GOOD, I WAS STANDING NEXT TO HER, SHE LOOKED PALE, SHE WAS PASSING OUT, I CALLED FOR HELP, PERSON FROM PHARMACY AND PERSON FROM MINUTE CLINIC CAME TO HELP. WE CALLED 911, HER BREATHING WAS REALLY SHALOE. GAVE HER EPIPEN. PT DID START TALKING AFTER COUPLE MINUTES. PARAMEDICS CAME AND EXAMINED HER , BP WA REALLY LOW. SHE WAS TAKEN TO HOSPITAL.
Presented to ER on 1/21/22 and found to be COVID19 positive. brought by EMS from unknown place with chief complaint of unresponsiveness,  And patient had PEA in ED and resuscitated and patient received 4 mg of epinephrine, 2 mg of Narcan, 1 amp of. bicarb and 1 g of calcium gluconate 2 times,  Patient regain pulse and intubated,  And then hospital team is called for admission, patient is already intubated, sedated and on ventilator at the time encounter. Patient also had developed acute kidney injury with metabolic acidosis. He self extubated himself on the night of 01/27/2022.  Since then has been agitated and confused. On 01/30/2022 he did have worsening respiratory failure with increased work of breathing and tachypnea on OptiFlow. Eventually family decided to proceed with comfort care. Deceased on 1/31/22.
Shortly after vaccination client felt intense pain in  the right side of  her neck radiating down her arm. Client was at the vaccination site in the observation lot at this time, and the Nurse called the ambulance to come assess the client. The client was transported to the ER with the consent of the mother.
I experienced the following side effects starting at 9:00 p.m.: Significant all-over body pain, severe headaches, dizziness, lethargy, fatigue, chills, hot flashes
Fever (102 degrees), cold sweats, nausea, body aches throughout night. Feeling better next day, no treatment except ibuprofen.
No additional adverse event; Patient administered vaccine after a temperature excursion.; This spontaneous report was received from registered nurse and refers to a patient of unknown age and gender. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided.  On 27-JUL-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, lot # U025789 confirmed to be valid with an expiration date 19-AUG-2023 (exact dose, route of administration, anatomical location were not reported) for prophylaxis. The vaccine underwent a temperature excursion of - 13.994 degrees Celsius (C) for 1 hour and 20 minutes (product storage error). There was no previous temperature excursion. No additional adverse event was reported.
followed by very cold, and a headache. At night I started a lot of nasal fluid, accompanied by coughing and intense body pain and fatigue. All day on Saturday. And today Sunday the 9th I continue with nasal fluid and headache. I am taking adviel every 6 hours to help with the headache and body pain and lots of fluids.
The patient passed out within 15 minutes once moved from table to chair.; The patient's father felt that the patient had a seizure and was insisting that the patient see a neurologist.; This spontaneous report was received from a Nurse Practitioner via company representative, referring to an 11 year old female patient. The patient's medical history, concurrent conditions, and historical drugs were not reported.  On an unknown date in October 2020, the patient was vaccinated with her first dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9)(strength, route, frequency, anatomical location, lot # and expiration date were unknown) via intramuscular route for prophylaxis. Additionally, the patient was vaccinated concomitantly with diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid(TDAP) and meningococcal acyw conj vaccine (dip toxoid)(MENACTRA) on the same date.  The Nurse Practitioner reported that the patient passed out (loss of consciousness) within 15 minutes once she moved from the table to the chair. Further, the nurse stated that the patient's father felt that the patient had a seizure and was insisting that the patient seek for a neurologist.  At the time of the report, the outcome of loss of consciousness and seizure was reported as resolved on an unknown date. The reporter did not mention the causality assessment between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) vaccination.
Injection site red, painful, warm to touch, itchy swollen, 9 cm x 7 cm of redness.
Initially had headache and arm pain, but injection site became red and swollen 1 week later.
Information has been received from a consumer concerning her second child who on an unspecified date was vaccinated with PEDVAXHIB (manufacturer unknown). The patient developed high fever after receiving the "HIB vaccine". The outcome of the patient's high fever was not reported. This is one of several reports from the same source. No further information is available.
A report has been received from a Health Professional concerning a 3 years male patient Height 40.0 inches; Weight 34.0 Pounds, who had been receiving Nasal FLUMIST Quadrivalent (Intranasal),  0.2 Milliliters, unknown for flu vaccine. It was reported that patient had been taken expired medication FLUMIST Quadrivalent (Intranasal) was discontinued on 04-FEB-2016. The report was considered to be non-serious. 24-Mar-2016: Corrected report 24-Mar-2016: Reporter details were corrected and auto narrative has been done.
L thigh has bruise 3 cm diameter and area of erythema 21cm x 12cm.